PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

First 3D real-time imaging of hydrogen’s effect on stainless steel defects opens the way to a safer hydrogen economy

2025-09-09
(Press-News.org) A study led by University of Oxford and Brookhaven National Laboratory researchers has uncovered how exposure to hydrogen atoms dynamically alters the internal structure of stainless steel. The findings reveal that hydrogen allows internal defects in steel to move in ways not normally possible – which can lead to unexpected failure. This discovery offers vital insights that could help make hydrogen fuel systems safer and more reliable, from aircraft and fusion reactors to pipelines and storage tanks. The study has been published today (9 Sept) in Advanced Materials. In a world-first experiment, the team used an advanced X-ray imaging technique to track how tiny defects inside stainless steel (called dislocations) respond to hydrogen exposure. This is crucial to understand how hydrogen can cause metals to weaken or fail, and could guide the design of next-generation alloys for a growing hydrogen economy.

Lead researcher Dr. David Yang (Brookhaven National Laboratory) said: “Hydrogen has great potential as a clean energy carrier, but it’s notorious for making materials it comes in contact with more brittle. For the first time, we have directly observed how hydrogen changes the way defects in stainless steel behave deep inside the metal, under realistic conditions. This knowledge is essential for designing alloys that are more resilient in extreme environments, including future hydrogen-powered aircraft and nuclear fusion plants.”

As countries aim to transition to fossil-free energy systems, hydrogen has been touted as the ideal fuel for ‘hard to decarbonise’ sectors, such as shipping, aviation, and heavy freight. However, hydrogen can cause unexpected cracking in metals (known as hydrogen embrittlement) which threatens the integrity of high-pressure vessels, pipelines, and critical components in energy systems.

While engineers have long known that hydrogen affects metal performance, the precise mechanisms at the atomic scale have remained elusive, as hydrogen is very difficult to detect.

Study principal investigator Prof. Felix Hofmann (Department of Engineering Science, University of Oxford) explained: “Using coherent X-ray diffraction, a non-destructive method, we were able to watch atomic-scale events unfold in real time inside solid metal without cutting open the sample. It has been tremendously exciting analysing this data and piecing together the parts of this scientific puzzle. Some of the results really surprised us by showing up behaviour we weren’t expecting.”

To uncover what hydrogen does inside the material, the researchers used an ultra-bright beamline at the Advanced Photon Source in the US to focus X-rays onto a single stainless-steel grain, roughly 700 nanometres in diameter. They then applied a technique called Bragg Coherent Diffraction Imaging to measure how the internal structure of this grain changed over time. In this method, the X-rays are scattered by the crystal lattice, creating a complex interference pattern. This can be reconstructed to reveal the structure of the grain, the crystal defects within it and how they distort the lattice around them.

By imaging the steel grain over 12 hours, the experiment revealed three key changes once hydrogen was introduced:

Dislocations became unexpectedly mobile. Internal faults began to move and reshape themselves, even without additional external stress. This suggests that hydrogen acts like a lubricant at the atomic scale, making it possible for defects to move more easily. A surprising out-of-plane motion of defects was observed. This upward shift, known as “climb,” is unexpected and signals that hydrogen allows atoms to rearrange in ways that aren’t typically possible at room temperature. This process is thought to play a critical role in reducing the hardness of alloys. The dislocation’s surrounding strain field reduced noticeably as hydrogen accumulated. A strain field is the zone around a defect where atoms are pushed or pulled out of place, allowing the material to accommodate the defect. This study provides the first direct, 3D experimental measurement of a long-theorised effect called hydrogen elastic shielding, where hydrogen reduces defect strain fields, effectively shielding the surrounding metal from stress. These findings help explain why hydrogen can lead to unexpected failure in metals since it allows internal defects to move more easily and in ways that are not normally possible.

According to the researchers, the work directly informs how to model and predict material performance in hydrogen environments, feeding into multi-scale simulation frameworks used by industry. It also points toward potential strategies for engineering novel alloys that offer greater resistance to hydrogen embrittlement.

Professor Hoffman added: “This research is only possible because of the availability of extremely bright and coherent X-ray beams at international synchrotron sources. The results are highly complementary to information from electron microscopy and simulations. We are now planning even more sophisticated experiments to study how hydrogen changes other types of defects. At the same time, we’re also developing models to help industry design complex hydrogen fuel systems.”

The study also involved researchers from Argonne National Laboratory (United States), and University College London.

Notes to editors:

For media enquiries and interview requests, contact: Professor Felix Hofmann felix.hofmann@eng.ox.ac.uk

The study ‘Direct Imaging of Hydrogen-Driven Dislocation and Strain Field Evolution in a Stainless Steel Grain’ will be published in Advanced Materials at 11:00 am BST Tuesday 9 September 2025 at https://advanced.onlinelibrary.wiley.com/doi/10.1002/adma.202500221 To view a copy of the study before this under embargo contact: Professor Felix Hofmann felix.hofmann@eng.ox.ac.uk

About the University of Oxford

Oxford University has been placed number 1 in the Times Higher Education World University Rankings for the ninth year running, and ​number 3 in the QS World Rankings 2024. At the heart of this success are the twin-pillars of our ground-breaking research and innovation and our distinctive educational offer.

Oxford is world-famous for research and teaching excellence and home to some of the most talented people from across the globe. Our work helps the lives of millions, solving real-world problems through a huge network of partnerships and collaborations. The breadth and interdisciplinary nature of our research alongside our personalised approach to teaching sparks imaginative and inventive insights and solutions.

Through its research commercialisation arm, Oxford University Innovation, Oxford is the highest university patent filer in the UK and is ranked first in the UK for university spinouts, having created more than 300 new companies since 1988. Over a third of these companies have been created in the past five years. The university is a catalyst for prosperity in Oxfordshire and the United Kingdom, contributing around £16.9 billion to the UK economy in 2021/22, and supports more than 90,400 full time jobs.

About Brookhaven National Laboratory

Brookhaven National Laboratory is supported by the Office of Science of the U.S. Department of Energy. The Office of Science is the single largest supporter of basic research in the physical sciences in the United States and is working to address some of the most pressing challenges of our time. For more information, visit science.energy.gov.

 

END


ELSE PRESS RELEASES FROM THIS DATE:

Circulating tumor DNA may guide immunotherapy use in limited-stage SCLC, new study shows

2025-09-09
(Barcelona, Spain September 9, 2025, 10:15 a.m. CEST / UTC +2) — A new study presented at the International Association for the Study of Lung Cancer 2025 World Conference on Lung Cancer (WCLC) demonstrates that monitoring circulating tumor DNA (ctDNA) can refine and personalize the use of consolidation immunotherapy in patients with limited-stage small cell lung cancer (LS-SCLC). The research, led by scientists at the National Cancer Center of China, assessed ctDNA in 177 patients with LS-SCLC treated with chemoradiotherapy (CCRT), 77 of whom received consolidation immune checkpoint inhibitors (ICIs). Circulating tumor DNA was measured ...

Novel immunotherapy strategy shows promising long-term survival in advanced NSCLC patients with inadequate response to immune checkpoint inhibitors

2025-09-09
(Barcelona, Spain September 9, 2025, 10:15 a.m. CEST / UTC +2) – A new study presented today reports encouraging long-term survival outcomes from an experimental viral  immunotherapy, CAN-2409, in patients with advanced non-small cell lung cancer (NSCLC) who previously failed to respond adequately to immune checkpoint inhibitors (ICI). The study was presented at the International Association for the Study of Lung Cancer (IASLC) 2025 World Conference on Lung Cancer. The phase 2a clinical trial investigated the efficacy of two intratumoral injections of CAN-2409 combined with an oral prodrug (valacyclovir) in ...

Surgery after EGFR TKI shows promise in prolonging progression-free survival in metastatic NSCLC

2025-09-09
(Barcelona, Spain September 9, 2025, 10:15 a.m. CEST / UTC +2) — A randomized Phase II trial from National Taiwan University Hospital reports early evidence that resecting the primary thoracic tumor following EGFR tyrosine kinase inhibitor (TKI) therapy may prolong disease control in patients with metastatic EGFR-mutated non-small cell lung cancer (NSCLC). The study was presented today at the International Association for the Study of Lung Cancer 2025 World Conference on Lung Cancer (WCLC). The trial, which enrolled both oligometastatic and polymetastatic patients, is the first to assess  surgical ...

Lung Cancer Europe study highlights communication gaps and need for shared decision-making

2025-09-09
(Barcelona, Spain September 9, 2025, 10:15 a.m. CEST / UTC +2)  — A large-scale survey conducted by Lung Cancer Europe (LuCE) has identified critical communication barriers that affect information access, understanding, and shared decision-making among lung cancer patients and caregivers across Europe. The research was reported at the International Association for the Study of Lung Cancer 2025 World Conference on Lung Cancer (WCLC). The study, based on 2,040 valid survey responses from 34 WHO European Region countries in 20 languages, evaluated three key areas: general knowledge about lung cancer, access to information, ...

FANSS study demonstrates feasibility of U.S.-based lung cancer screening in Asian female nonsmokers

2025-09-09
(Barcelona, Spain September 9, 2025, 10:15 a.m. CEST / UTC +2)  — Results from the Female Asian Nonsmoker Screening Study (FANSS) highlight the potential value of low-dose CT (LDCT) screening for lung cancer among a growing but underserved population: Asian women with no history of smoking. The study results were reported today at the International Association for the Study of Lung Cancer 2025 World Conference on Lung Cancer (WCLC). FANSS is the first known lung cancer screening program in the U.S. dedicated exclusively to ...

Well-publicized polar geoengineering ideas will not help and could harm, warn experts

2025-09-09
Five well-publicized polar geoengineering ideas are highly unlikely to help the polar regions and could harm ecosystems, communities, international relations, and our chances of reaching net zero by 2050.  This is according to a new assessment, published in Frontiers in Science, which looked at five of the most developed geoengineering proposals currently being considered for use in Antarctica and the Arctic.  The polar regions are home to fragile communities and ecosystems, as well as most of the world’s ice. Technological ‘geoengineering’ approaches have been proposed to delay or address the impacts of climate ...

Racial stereotypes can make us see weapons where they don’t exist

2025-09-09
Unarmed Black civilians are three times more likely to be shot and killed by police officers than unarmed white civilians in the U.S. In tragic cases in recent years, unarmed Black men holding innocuous objects like a wallet, cell phone, or vape pen were killed by police officers because those objects were misidentified as weapons. These split-second fatal mistakes, often under ambiguous and stressful conditions, have sparked urgent debates about their causes and how to fix them. A new brain-imaging study from researchers at Columbia University ...

“Bottlebrush” particles deliver big chemotherapy payloads directly to cancer cells

2025-09-09
CAMBRIDGE, MA -- Using tiny particles shaped like bottlebrushes, MIT chemists have found a way to deliver a large range of chemotherapy drugs directly to tumor cells. To guide them to the right location, each particle contains an antibody that targets a specific tumor protein. This antibody is tethered to bottlebrush-shaped polymer chains carrying dozens or hundreds of drug molecules — a much larger payload than can be delivered by any existing antibody-drug conjugates. In mouse models of breast and ovarian cancer, the researchers found that treatment with ...

New AI tool pinpoints genes, drug combos to restore health in diseased cells

2025-09-09
In a move that could reshape drug discovery, researchers at Harvard Medical School have designed an artificial intelligence model capable of identifying treatments that reverse disease states in cells. Unlike traditional approaches that typically test one protein target or drug at a time in hopes of identifying an effective treatment, the new model, called PDGrapher and available for free, focuses on multiple drivers of disease and identifies the genes most likely to revert diseased cells back to healthy function. The ...

Predicting where deadly brain cancer may spread next

2025-09-09
Glioblastoma is a devastatingly effective brain cancer. Doctors can cut it out or blast it with radiation, but that only buys time. The cancer has an insidious ability to hide enough tumor cells in tissue around the tumor to allow it to return as deadly as ever. Patients diagnosed with glioblastoma survive for an average of 15 months. What’s needed is a better way of identifying those hidden cancer cells and predicting where the tumor might grow next. Jennifer Munson believes she and her research team at the Fralin Biomedical Research Institute at VTC have developed a tool to do just that. Their method, described ...

LAST 30 PRESS RELEASES:

Scientists agree chemicals can affect behavior, but industry workers more reluctant about safety testing

DNA nanospring measures cellular motor power

Elsevier Foundation and RIKEN launch “Envisioning Futures” report: paving the way for gender equity and women’s leadership in Japanese research

Researchers discover enlarged areas of the spinal cord in fish, previously found only in four-limbed vertebrates

Bipolar disorder heterogeneity decoded: transforming global psychiatric treatment approaches

Catching Alport syndrome through universal age-3 urine screening

Instructions help you remember something better than emotions or a good night’s sleep

Solar energy is now the world’s cheapest source of power, a Surrey study finds

Scientists reverse Alzheimer’s in mice using nanoparticles

‘Good’ gut bacteria boosts placenta for healthier pregnancy

USC team demonstrates first optical device based on “optical thermodynamics”

Microplastics found to change gut microbiome in first human-sample study

Artificially sweetened and sugary drinks are both associated with an increased risk of liver disease, study finds

Plastic in the soil, but not as we know it: Biodegradable microplastics rewire carbon storage in farm fields

Yeast proteins reveal the secrets of drought resistance

Psychiatry, primary care, and OB/GYN subspecialties hit hardest by physician attrition

New Canadian study reveals where HIV hides in different parts of the body

Lidocaine poisonings rise despite overall drop in local anesthetic toxicity

Politics follow you on the road

Scientists blaze new path to fighting viral diseases

The mouse eye as a window to spotting systemic disease

AI and the Future of Cancer Research and Cancer Care to headline October 24 gathering of global oncology leaders at the National Press Club: NFCR Global Summit to feature top scientists, entrepreneurs

FDA clears UCLA heart tissue regeneration drug AD-NP1 for clinical trials

Exploring the therapeutic potential of cannabidiol for Alzheimer's

We need a solar sail probe to detect space tornadoes earlier, more accurately, U-M researchers say

Acute myeloid leukemia (AML): Disease risk but not remission status determines transplant outcomes – new ASAP long-term results

Sperm microRNAs: Key regulators of the paternal transmission of exercise capacity

Seeing double: Clever images open doors for brain research

Inhaler-related greenhouse gas emissions in the US

UCLA Health study finds inhalers for asthma and COPD drive significant greenhouse gas emissions

[Press-News.org] First 3D real-time imaging of hydrogen’s effect on stainless steel defects opens the way to a safer hydrogen economy